United States v. David Byron Copeland

Court of Appeals for the Eleventh Circuit·Decided January 9, 2026·No. 23-13888·Unpublished

Opinion

USCA11 Case: 23-13888 Document: 43-1 Date Filed: 01/09/2026 Page: 1 of 16

NOT FOR PUBLICATION

In the

United States Court of Appeals For the Eleventh Circuit

No. 23-13888

UNITED STATES OF AMERICA, Plaintiff-Appellee,

versus

DAVID BYRON COPELAND, Defendant-Appellant.

Appeal from the United States District Court for the Middle District of Florida D.C. Docket No. 8:20-cr-00165-MSS-AAS-3

Before NEWSOM and BRASHER, Circuit Judges, and HUCK,∗ District Judge. PER CURIAM:

∗ Honorable Paul C. Huck, United States District Judge for the Southern Dis-

trict of Florida, sitting by designation.

2 Opinion of the Court 23-13888

After trial in the Middle District of Florida, a jury found David Copeland guilty of two substantive counts of soliciting and receiving health care kickbacks and bribes, in violation of 42 U.S.C. § 1320a-7b(b)(1) and 18 U.S.C. § 2, and three substantive counts of offering and paying health care kickbacks and bribes, in violation of 42 U.S.C. § 1320a-7b(b)(2) and 18 U.S.C. § 2. The jury found Copeland not guilty of conspiracy to defraud the United States and to receive and pay healthcare kickbacks, in violation of 18 U.S.C. § 371. The district court sentenced Copeland to a below the guideline range of 51 months of imprisonment, to be followed by three years of supervised release. Copeland appeals both his convictions and sentence.

Copeland presents four arguments on appeal. First, as to the verdict, Copeland argues that the evidence was insufficient to support his convictions on the five substantive counts because he was acquitted of the conspiracy count, demonstrating an inconsistency in the jury verdicts. Second, as to his sentence, Copeland argues that the district court erred by (1) finding that Copeland qualified for an aggravating role enhancement as a manager or supervisor under U.S.S.G. § 3B1.1(b); (2) finding that Copeland was not entitled to a reduction in his offense level under U.S.S.G. § 4C1.1 because he was not a zero-point offender; and (3) finding that Copeland was not entitled to a reduction in his offense level under U.S.S.G. § 3E1.1(a) because he did not clearly demonstrate acceptance of responsibility over his offenses.

23-13888 Opinion of the Court 3

We disagree with Copeland on each issue and AFFIRM Copeland’s convictions and sentence.

I.

This case arises out of an illegal scheme to pay and receive kickbacks in violation of the Anti-Kickback Statute involving Florida Pharmacy Solutions, Inc. (“FPS”) and the TRICARE federal health care benefits program. Copeland, together with his co-defendant James Moss, were the sole owners and officers of FPS, a pharmacy that specialized in expensive compounded prescription pain and scar creams. TRICARE is a federal healthcare benefit program that is administered by the Department of Defense (“DOD”) and provides coverage to military service-members and their families . FPS produced the compounded prescription creams, and, through FPS’s sales representatives, marketed the creams to beneficiaries of TRICARE. In return, TRICARE would reimburse FPS.

On May 27, 2020, a superseding indictment charged Copeland with one count of conspiring to defraud the United States and to receive and pay healthcare kickbacks, in violation of 18 U.S.C. § 371 and 42 U.S.C. § 1320a-7b(b)(l), (2) (Count I); two counts of receiving healthcare kickbacks, in violation of 42 U.S.C. § 1320a-7b(b)(1) and 18 U.S.C. §2 (Counts II and III); and three counts of paying healthcare kickbacks, in violation of 42 U.S.C. § 1320a-7b(b)(2) and 18 U.S.C. § 2 (Counts IV through VI). The facts alleged in the superseding indictment are summarized as follows. Between 2012 and 2015, Copeland, Moss, and others associated

4 Opinion of the Court 23-13888

with FPS would solicit medical providers to prescribe FPS’s expensive compounded creams for use by TRICARE beneficiaries, which prescriptions were then sent to FPS to be filled. TRICARE would then pay for those prescriptions. These prescriptions were procured by direct and indirect payments of bribes and kickbacks to medical providers in order to induce them to prescribe FPS’s compounded creams and to have the creams be filled by FPS. As part of that scheme, FPS paid kickbacks to Copeland and others. In addition , Copeland, through FPS, paid kickbacks to co-Defendant Gordon and other sales representatives on Copeland’s sales team.

The Government presented the following evidence at trial. Moss testified that he and Copeland communicated with each other almost every day by phone and text, and that he conspired with Copeland to pay bribes and kickbacks to doctors, which included hunting trips, fishing trips, and trips to a casino, in exchange for the doctors continuing to write prescriptions for compounded creams to be filled by FPS. Moss testified that he discussed the hunting trips with Copeland, that Copeland asked Moss to pay for the hunting trips, and that the hunting trips Copeland went on were with doctors in Copeland’s sales territory. Moss testified that Copeland both solicited doctors directly and oversaw his sales team’s solicitations. Both Copeland and his sales team members were paid by commission, meaning they were paid a percentage of the money generated from the prescriptions they secured. Copeland received a commission on both his own sales and those

23-13888 Opinion of the Court 5

of his sales team. Moss testified that Copeland, as co-owner, also received dividends from FPS.

Moss also testified that on one occasion he texted Copeland about the expenses incurred for a hunting trip on which Eddie Jackson , a member of Copeland’s sales team, had taken three doctors, and which trip Copeland had approved. Moss testified that the hunting trip was a bribe for the doctors. Moss also testified that Rebekah Davis, another member of Copeland’s sales team, organized a wine and paint party for 12 to 15 nurses with the expectation that it would induce the nurses to write prescriptions for FPS’s compounded creams, and that Copeland was aware of the party and did not object to it. Moss also testified that in order to resolve a dispute between Copeland and Gordon regarding Copeland’s sales territory, FPS allocated a portion of Gordon’s commissions to Copeland. Moss also testified that Copeland’s contract with FPS required him to comply with applicable laws, including the Anti- Kickback Statute.

Gordon testified that he was paid by Copeland to solicit prescriptions from medical providers. He testified that he gave medical professionals breakfasts, lunches, dinners, and hunting trips to induce them to write prescriptions for TRICARE beneficiaries and send those prescriptions to FPS. Gordon testified that he discussed the details of these inducements with Copeland, including notifying Copeland when Gordon took doctors out to various dinners and when Gordon was successful in getting the doctors to submit prescriptions for FPS’s compounded creams. Gordon testified that

6 Opinion of the Court 23-13888

Copeland never told him to stop hosting the dinners. Gordon further testified that he took a doctor on a hunting trip to induce the doctor to continue writing prescriptions for FPS’s compounded creams, and that he was reimbursed by FPS for the entire trip.

Robert Matteis, a DOD special agent who investigated FPS, testified that he asked Copeland if anyone at FPS paid kickbacks to induce doctors to write prescriptions, which Copeland denied. Matteis testified that Copeland later acknowledged that an FPS salesman had taken doctors on hunting trips but denied participating in them, and stated that he only knew that FPS provided lunches to doctors.

Free access — add to your briefcase to read the full text and ask questions with AI

United States v. David Byron Copeland, (11th Cir. 2026).

United States v. David Byron Copeland (United States v. David Byron Copeland) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

United States v. Arguedas
86 F.3d 1054 (Eleventh Circuit, 1996)
United States v. Veal
153 F.3d 1233 (Eleventh Circuit, 1998)
United States v. Starks
157 F.3d 833 (Eleventh Circuit, 1998)
United States v. Michael Donyell Boyd
291 F.3d 1274 (Eleventh Circuit, 2002)
United States v. Daniel Francisco Ramirez
426 F.3d 1344 (Eleventh Circuit, 2005)
United States v. Jason Luntay Taylor
480 F.3d 1025 (Eleventh Circuit, 2007)
United States v. Powell
469 U.S. 57 (Supreme Court, 1984)
Desert Palace, Inc. v. Costa
539 U.S. 90 (Supreme Court, 2003)
Puckett v. United States
556 U.S. 129 (Supreme Court, 2009)
United States v. Thompson
610 F.3d 1335 (Eleventh Circuit, 2010)
United States v. Isabel Rodriguez De Varon
175 F.3d 930 (Eleventh Circuit, 1999)
United States v. Chris Vernon
723 F.3d 1234 (Eleventh Circuit, 2013)
United States v. Yosany Sosa
777 F.3d 1279 (Eleventh Circuit, 2015)
United States v. Carlos Rodriguez Nerey
877 F.3d 956 (Eleventh Circuit, 2017)
Rosales-Mireles v. United States
585 U.S. 129 (Supreme Court, 2018)
United States v. James Maarvin Hawkins
934 F.3d 1251 (Eleventh Circuit, 2019)
United States v. Clare Therese Grady
18 F.4th 1275 (Eleventh Circuit, 2021)
United States v. Baston
818 F.3d 651 (Eleventh Circuit, 2016)
United States v. Jason Gatlin
90 F.4th 1050 (Eleventh Circuit, 2024)